{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T06:38:47Z","timestamp":1792651127490,"version":"4.5.0"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,11,29]],"date-time":"2019-11-29T00:00:00Z","timestamp":1574985600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2019,11,29]],"date-time":"2019-11-29T00:00:00Z","timestamp":1574985600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Bundesgesundheitsbl"],"published-print":{"date-parts":[[2020,1]]},"DOI":"10.1007\/s00103-019-03060-3","type":"journal-article","created":{"date-parts":[[2019,11,29]],"date-time":"2019-11-29T09:04:46Z","timestamp":1575018286000},"page":"40-44","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":89,"title":["Dengue vaccine development: status and future","Entwicklung von Impfstoffen gegen Dengue: aktueller Stand und Zukunft"],"prefix":"10.1007","volume":"63","author":[{"given":"Annelies","family":"Wilder-Smith","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,11,29]]},"reference":[{"issue":"3","key":"3060_CR1","doi-asserted-by":"publisher","first-page":"e101","DOI":"10.1016\/S1473-3099(16)30518-7","volume":"17","author":"A Wilder-Smith","year":"2017","unstructured":"Wilder-Smith\u00a0A, Gubler\u00a0DJ, Weaver\u00a0SC, Monath\u00a0TP, Heymann\u00a0DL, Scott\u00a0TW (2017) Epidemic arboviral diseases: priorities for research and public health. Lancet Infect Dis 17(3):e101\u2013e106. https:\/\/doi.org\/10.1016\/S1473-3099(16)30518-7","journal-title":"Lancet Infect Dis"},{"key":"3060_CR2","doi-asserted-by":"publisher","DOI":"10.1093\/jtm\/taw062","author":"ES Jentes","year":"2016","unstructured":"Jentes\u00a0ES, Lash\u00a0RR, Johansson\u00a0MA, Sharp\u00a0TM, Henry\u00a0R, Brady\u00a0OJ et al (2016) Evidence-based risk assessment and communication: a\u00a0new global dengue-risk map for travellers and clinicians. J\u00a0Travel Med. https:\/\/doi.org\/10.1093\/jtm\/taw062","journal-title":"J Travel Med"},{"key":"3060_CR3","doi-asserted-by":"publisher","DOI":"10.1093\/jtm\/tay061","author":"S Masyeni","year":"2018","unstructured":"Masyeni\u00a0S, Yohan\u00a0B, Somia\u00a0IKA, Myint\u00a0KSA, Sasmono\u00a0RT (2018) Dengue infection in international travellers visiting Bali, Indonesia. J\u00a0Travel Med. https:\/\/doi.org\/10.1093\/jtm\/tay061","journal-title":"J Travel Med"},{"key":"3060_CR4","doi-asserted-by":"publisher","DOI":"10.1093\/jtm\/tax015","author":"A Riddell","year":"2017","unstructured":"Riddell\u00a0A, Babiker\u00a0ZO (2017) Imported dengue fever in East London: a\u00a06-year retrospective observational study. J\u00a0Travel Med. https:\/\/doi.org\/10.1093\/jtm\/tax015","journal-title":"J Travel Med"},{"issue":"10169","key":"3060_CR5","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1016\/S0140-6736(18)32560-1","volume":"393","author":"A Wilder-Smith","year":"2019","unstructured":"Wilder-Smith\u00a0A, Ooi\u00a0EE, Horstick\u00a0O, Wills\u00a0B (2019) Dengue. Lancet 393(10169):350\u2013363. https:\/\/doi.org\/10.1016\/S0140-6736(18)32560-1","journal-title":"Lancet"},{"issue":"6365","key":"3060_CR6","doi-asserted-by":"publisher","first-page":"929","DOI":"10.1126\/science.aan6836","volume":"358","author":"LC Katzelnick","year":"2017","unstructured":"Katzelnick\u00a0LC, Gresh\u00a0L, Halloran\u00a0ME, Mercado\u00a0JC, Kuan\u00a0G, Gordon\u00a0A et al (2017) Antibody-dependent enhancement of severe dengue disease in humans. Science 358(6365):929\u2013932. https:\/\/doi.org\/10.1126\/science.aan6836","journal-title":"Science"},{"key":"3060_CR7","doi-asserted-by":"publisher","DOI":"10.1186\/s12889-017-4289-5","author":"N Andersson","year":"2017","unstructured":"Andersson\u00a0N, Arostegui\u00a0J, Nava-Aguilera\u00a0E, Harris\u00a0E, Ledogar\u00a0RJ (2017) Camino Verde (The Green Way): evidence-based community mobilisation for dengue control in Nicaragua and Mexico: feasibility study and study protocol for a\u00a0randomised controlled trial. BMC Public Health. https:\/\/doi.org\/10.1186\/s12889-017-4289-5","journal-title":"BMC Public Health"},{"issue":"1","key":"3060_CR8","doi-asserted-by":"publisher","first-page":"e0005197","DOI":"10.1371\/journal.pntd.0005197","volume":"11","author":"P Kittayapong","year":"2017","unstructured":"Kittayapong\u00a0P, Olanratmanee\u00a0P, Maskhao\u00a0P, Byass\u00a0P, Logan\u00a0J, Tozan\u00a0Y et al (2017) Mitigating diseases transmitted by aedes mosquitoes: a cluster-randomised trial of permethrin-impregnated school uniforms. PLoS Negl Trop Dis 11(1):e5197\u201328103255. https:\/\/doi.org\/10.1371\/journal.pntd.0005197","journal-title":"PLoS Negl Trop Dis"},{"key":"3060_CR9","doi-asserted-by":"publisher","DOI":"10.1093\/jtm\/tay084","author":"SA Ritchie","year":"2018","unstructured":"Ritchie\u00a0SA (2018) Wolbachia and the near cessation of dengue outbreaks in Northern Australia despite continued dengue importations via travellers. J\u00a0Travel Med. https:\/\/doi.org\/10.1093\/jtm\/tay084","journal-title":"J Travel Med"},{"key":"3060_CR10","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(16)00026-8","author":"JD Stanaway","year":"2016","unstructured":"Stanaway\u00a0JD, Shepard\u00a0DS, Undurraga\u00a0EA, Halasa\u00a0YA, Coffeng\u00a0LE, Brady\u00a0OJ et\u00a0al (2016) The global burden of dengue: an analysis from the Global Burden of Disease Study. Lancet Infect Dis. https:\/\/doi.org\/10.1016\/S1473-3099(16)00026-8","journal-title":"Lancet Infect Dis"},{"issue":"12","key":"3060_CR11","doi-asserted-by":"publisher","first-page":"1155","DOI":"10.1056\/NEJMoa1503877","volume":"374","author":"M L\u2019Azou","year":"2016","unstructured":"L\u2019Azou\u00a0M, Moureau\u00a0A, Sarti\u00a0E, Nealon\u00a0J, Zambrano\u00a0B, Wartel\u00a0TA et\u00a0al (2016) Symptomatic Dengue in children in 10 asian and latin American countries. N\u00a0Engl J Med 374(12):1155\u20131166. https:\/\/doi.org\/10.1056\/NEJMoa1503877","journal-title":"N Engl J Med"},{"issue":"36","key":"3060_CR12","doi-asserted-by":"publisher","first-page":"4659","DOI":"10.1016\/j.vaccine.2017.07.045","volume":"35","author":"LC Katzelnick","year":"2017","unstructured":"Katzelnick\u00a0LC, Harris\u00a0E (2017) Participants in the summit on Dengue immune correlates of P. Immune correlates of protection for dengue: state of the art and research agenda. Vaccine 35(36):4659\u20134669. https:\/\/doi.org\/10.1016\/j.vaccine.2017.07.045","journal-title":"Vaccine"},{"key":"3060_CR13","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1506223","author":"SR Hadinegoro","year":"2015","unstructured":"Hadinegoro\u00a0SR, Arredondo-Garcia\u00a0JL, Capeding\u00a0MR, Deseda\u00a0C, Chotpitayasunondh\u00a0T, Dietze\u00a0R et al (2015) Efficacy and long-term safety of a\u00a0dengue vaccine in regions of endemic disease. N\u00a0Engl J Med. https:\/\/doi.org\/10.1056\/NEJMoa1506223","journal-title":"N Engl J Med"},{"issue":"2","key":"3060_CR14","doi-asserted-by":"publisher","first-page":"302","DOI":"10.4269\/ajtmh.2009.80.302","volume":"80","author":"B Guy","year":"2009","unstructured":"Guy\u00a0B, Barban\u00a0V, Mantel\u00a0N, Aguirre\u00a0M, Gulia\u00a0S, Pontvianne\u00a0J et\u00a0al (2009) Evaluation of interferences between dengue vaccine serotypes in a\u00a0monkey model. Am J Trop Med Hyg 80(2):302\u2013311","journal-title":"Am J Trop Med Hyg"},{"key":"3060_CR15","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1800820","author":"S Sridhar","year":"2018","unstructured":"Sridhar\u00a0S, Luedtke\u00a0A, Langevin\u00a0E, Zhu\u00a0M, Bonaparte\u00a0M, Machabert\u00a0T et\u00a0al (2018) Effect of dengue serostatus on Dengue vaccine safety and efficacy. N\u00a0Engl J Med. https:\/\/doi.org\/10.1056\/NEJMoa1800820","journal-title":"N Engl J Med"},{"key":"3060_CR16","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(18)30494-8","author":"A Wilder-Smith","year":"2018","unstructured":"Wilder-Smith\u00a0A, Hombach\u00a0J, Ferguson\u00a0N, Selgelid\u00a0M, O\u2019Brien\u00a0K, Vannice\u00a0K et al (2018) Deliberations of the strategic advisory group of experts on immunization on the use of CYD-TDV dengue vaccine. Lancet Infect Dis. https:\/\/doi.org\/10.1016\/S1473-3099(18)30494-8","journal-title":"Lancet Infect Dis"},{"issue":"3","key":"3060_CR17","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1080\/21645515.2018.1522468","volume":"15","author":"HJ Larson","year":"2019","unstructured":"Larson\u00a0HJ, Hartigan-Go\u00a0K, de Figueiredo\u00a0A (2019) Vaccine confidence plummets in the Philippines following dengue vaccine scare: why it matters to pandemic preparedness. Hum Vaccin Immunother 15(3):625\u2013627. https:\/\/doi.org\/10.1080\/21645515.2018.1522468","journal-title":"Hum Vaccin Immunother"},{"key":"3060_CR18","doi-asserted-by":"publisher","DOI":"10.1093\/jtm\/tay080","author":"WY Leong","year":"2018","unstructured":"Leong\u00a0WY (2018) Measles cases hit record high in Europe in 2018. J\u00a0Travel Med. https:\/\/doi.org\/10.1093\/jtm\/tay080","journal-title":"J Travel Med"},{"key":"3060_CR19","doi-asserted-by":"publisher","DOI":"10.1093\/jtm\/tay091","author":"E Massad","year":"2018","unstructured":"Massad\u00a0E (2018) Measles and human movement in Europe. J\u00a0Travel Med. https:\/\/doi.org\/10.1093\/jtm\/tay091","journal-title":"J Travel Med"},{"issue":"4","key":"3060_CR20","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1016\/S1473-3099(19)30129-X","volume":"19","author":"S Cousins","year":"2019","unstructured":"Cousins\u00a0S (2019) Measles: a\u00a0global resurgence. Lancet Infect Dis 19(4):362\u2013363. https:\/\/doi.org\/10.1016\/S1473-3099(19)30129-X","journal-title":"Lancet Infect Dis"},{"key":"3060_CR21","first-page":"457","volume":"93","author":"Dengue vaccine","year":"2018","unstructured":"Dengue vaccine (2018) WHO position paper-September 2018. Wkly Epidemiol Rec 93:457\u2013476","journal-title":"Wkly Epidemiol Rec"},{"key":"3060_CR22","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2019.07.016","author":"A Wilder-Smith","year":"2019","unstructured":"Wilder-Smith\u00a0A, Smith\u00a0PG, Luo\u00a0R, Kelly-Cirino\u00a0C, Curry\u00a0D, Larson\u00a0H et al (2019) Pre-vaccination screening strategies for the use of the CYD-TDV dengue vaccine: A meeting report. Vaccine. https:\/\/doi.org\/10.1016\/j.vaccine.2019.07.016","journal-title":"Vaccine"},{"issue":"24","key":"3060_CR23","doi-asserted-by":"publisher","first-page":"3411","DOI":"10.1016\/j.vaccine.2018.02.062","volume":"36","author":"KS Vannice","year":"2018","unstructured":"Vannice\u00a0KS, Wilder-Smith\u00a0A, Barrett\u00a0ADT, Carrijo\u00a0K, Cavaleri\u00a0M, de Silva\u00a0A et al (2018) Clinical development and regulatory points for consideration for second-generation live attenuated dengue vaccines. Vaccine 36(24):3411\u20133417. https:\/\/doi.org\/10.1016\/j.vaccine.2018.02.062","journal-title":"Vaccine"},{"issue":"1","key":"3060_CR24","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1186\/s12874-018-0601-z","volume":"18","author":"T Jaenisch","year":"2018","unstructured":"Jaenisch\u00a0T, Hendrickx\u00a0K, Erpicum\u00a0M, Agulto\u00a0L, Tomashek\u00a0KM, Dempsey\u00a0W et\u00a0al (2018) Development of standard clinical endpoints for use in dengue interventional trials: introduction and methodology. BMC Med Res Methodol 18(1):134. https:\/\/doi.org\/10.1186\/s12874-018-0601-z","journal-title":"BMC Med Res Methodol"},{"issue":"4","key":"3060_CR25","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1586\/14760584.2016.1128328","volume":"15","author":"JE Osorio","year":"2016","unstructured":"Osorio\u00a0JE, Wallace\u00a0D, Stinchcomb\u00a0DT (2016) A recombinant, chimeric tetravalent dengue vaccine candidate based on a\u00a0dengue virus serotype 2 backbone. Expert Rev Vaccines 15(4):497\u2013508. https:\/\/doi.org\/10.1586\/14760584.2016.1128328","journal-title":"Expert Rev Vaccines"},{"issue":"2","key":"3060_CR26","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1016\/S1473-3099(17)30632-1","volume":"18","author":"X Saez-Llorens","year":"2018","unstructured":"Saez-Llorens\u00a0X, Tricou\u00a0V, Yu\u00a0D, Rivera\u00a0L, Jimeno\u00a0J, Villarreal\u00a0AC et al (2018) Immunogenicity and safety of one versus two doses of tetravalent dengue vaccine in healthy children aged 2\u201317 years in Asia and Latin America: 18-month interim data from a\u00a0phase 2, randomised, placebo-controlled study. Lancet Infect Dis 18(2):162\u2013170. https:\/\/doi.org\/10.1016\/S1473-3099(17)30632-1","journal-title":"Lancet Infect Dis"},{"issue":"5","key":"3060_CR27","doi-asserted-by":"publisher","first-page":"702","DOI":"10.1093\/infdis\/jiv082","volume":"212","author":"BD Kirkpatrick","year":"2015","unstructured":"Kirkpatrick\u00a0BD, Durbin\u00a0AP, Pierce\u00a0KK, Carmolli\u00a0MP, Tibery\u00a0CM, Grier\u00a0PL et al (2015) Robust and balanced immune responses to all 4 dengue virus serotypes following administration of a\u00a0single dose of a\u00a0live attenuated tetravalent dengue vaccine to healthy, Flavivirus-naive adults. J\u00a0Infect Dis 212(5):702\u2013710. https:\/\/doi.org\/10.1093\/infdis\/jiv082","journal-title":"J Infect Dis"},{"issue":"4","key":"3060_CR28","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1586\/14760584.2016.1115727","volume":"15","author":"SS Whitehead","year":"2016","unstructured":"Whitehead\u00a0SS (2016) Development of TV003\/TV005, a\u00a0single dose, highly immunogenic live attenuated dengue vaccine; what makes this vaccine different from the Sanofi-Pasteur CYD vaccine? Expert Rev Vaccines 15(4):509\u2013517. https:\/\/doi.org\/10.1586\/14760584.2016.1115727","journal-title":"Expert Rev Vaccines"},{"issue":"1","key":"3060_CR29","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1128\/JVI.02129-14","volume":"89","author":"D Weiskopf","year":"2015","unstructured":"Weiskopf\u00a0D, Angelo\u00a0MA, Bangs\u00a0DJ, Sidney\u00a0J, Paul\u00a0S, Peters\u00a0B et\u00a0al (2015) The human CD8+ T cell responses induced by a\u00a0live attenuated tetravalent dengue vaccine are directed against highly conserved epitopes. J\u00a0Virol 89(1):120\u2013128. https:\/\/doi.org\/10.1128\/JVI.02129-14","journal-title":"J Virol"},{"key":"3060_CR30","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.02147-16","author":"MA Angelo","year":"2017","unstructured":"Angelo\u00a0MA, Grifoni\u00a0A, O\u2019Rourke\u00a0PH, Sidney\u00a0J, Paul\u00a0S, Peters\u00a0B et\u00a0al (2017) Human CD4+ T cell responses to an attenuated tetravalent Dengue vaccine parallel those induced by natural infection in magnitude, HLA restriction, and antigen specificity. J\u00a0Virol. https:\/\/doi.org\/10.1128\/JVI.02147-16","journal-title":"J Virol"},{"key":"3060_CR31","doi-asserted-by":"publisher","DOI":"10.1093\/jtm\/taz062","author":"S Halstead","year":"2019","unstructured":"Halstead\u00a0S, Wilder-Smith\u00a0A (2019) Severe dengue in travellers: pathogenesis, risk and clinical management. J\u00a0Travel Med. https:\/\/doi.org\/10.1093\/jtm\/taz062","journal-title":"J Travel Med"},{"issue":"5","key":"3060_CR32","doi-asserted-by":"publisher","first-page":"914","DOI":"10.3201\/eid1705.101023","volume":"17","author":"JA Streit","year":"2011","unstructured":"Streit\u00a0JA, Yang\u00a0M, Cavanaugh\u00a0JE, Polgreen\u00a0PM (2011) Upward trend in Dengue incidence among hospitalized patients, United States. Emerg Infect Dis 17(5):914\u2013916. https:\/\/doi.org\/10.3201\/eid1705.101023","journal-title":"Emerg Infect Dis"},{"issue":"6","key":"3060_CR33","doi-asserted-by":"publisher","first-page":"412","DOI":"10.3109\/00365548.2014.887222","volume":"46","author":"J Rocklov","year":"2014","unstructured":"Rocklov\u00a0J, Lohr\u00a0W, Hjertqvist\u00a0M, Wilder-Smith\u00a0A (2014) Attack rates of dengue fever in Swedish travellers. J\u00a0INFECT DIS 46(6):412\u2013417. https:\/\/doi.org\/10.3109\/00365548.2014.887222","journal-title":"J INFECT DIS"},{"key":"3060_CR34","doi-asserted-by":"publisher","DOI":"10.2807\/1560-7917.ES.2017.22.1.30433","author":"A Neumayr","year":"2017","unstructured":"Neumayr\u00a0A, Munoz\u00a0J, Schunk\u00a0M, Bottieau\u00a0E, Cramer\u00a0J, Calleri\u00a0G et\u00a0al (2017) Sentinel surveillance of imported dengue via travellers to Europe 2012 to 2014: tropnet data from the denguetools research initiative. Euro Surveill. https:\/\/doi.org\/10.2807\/1560-7917.ES.2017.22.1.30433","journal-title":"Euro Surveill"},{"key":"3060_CR35","doi-asserted-by":"publisher","DOI":"10.1093\/jtm\/tay139","author":"A Wilder-Smith","year":"2018","unstructured":"Wilder-Smith\u00a0A, Boggild\u00a0AK (2018) Sentinel surveillance in travel medicine: 20 years of geosentinel publications (1999\u20132018). J\u00a0Travel Med. https:\/\/doi.org\/10.1093\/jtm\/tay139","journal-title":"J Travel Med"},{"issue":"6","key":"3060_CR36","doi-asserted-by":"publisher","first-page":"456","DOI":"10.7326\/0003-4819-158-6-201303190-00005","volume":"158","author":"K Leder","year":"2013","unstructured":"Leder\u00a0K, Torresi\u00a0J, Libman\u00a0MD, Cramer\u00a0JP, Castelli\u00a0F, Schlagenhauf\u00a0P et\u00a0al (2013) GeoSentinel surveillance of illness in returned travelers, 2007\u20132011. Ann Intern Med 158(6):456\u2013468. https:\/\/doi.org\/10.7326\/0003-4819-158-6-201303190-00005","journal-title":"Ann Intern Med"},{"key":"3060_CR37","doi-asserted-by":"publisher","DOI":"10.1093\/jtm\/tax097","author":"LH Chen","year":"2018","unstructured":"Chen\u00a0LH, Leder\u00a0K, Barbre\u00a0KA, Schlagenhauf\u00a0P, Libman\u00a0M, Keystone\u00a0J et al (2018) Business travel-associated illness: a\u00a0GeoSentinel analysis. J\u00a0Travel Med. https:\/\/doi.org\/10.1093\/jtm\/tax097","journal-title":"J Travel Med"},{"key":"3060_CR38","doi-asserted-by":"publisher","DOI":"10.1093\/jtm\/taw003","author":"A Neuberger","year":"2016","unstructured":"Neuberger\u00a0A, Turgeman\u00a0A, Lustig\u00a0Y, Schwartz\u00a0E (2016) Dengue fever among Israeli expatriates in Delhi, 2015: implications for dengue incidence in Delhi, India. J\u00a0Travel Med. https:\/\/doi.org\/10.1093\/jtm\/taw003","journal-title":"J Travel Med"},{"issue":"9","key":"3060_CR39","doi-asserted-by":"publisher","first-page":"1185","DOI":"10.1086\/507893","volume":"43","author":"K Leder","year":"2006","unstructured":"Leder\u00a0K, Tong\u00a0S, Weld\u00a0L, Kain\u00a0KC, Wilder-Smith\u00a0A, von Sonnenburg\u00a0F et al (2006) Illness in travelers visiting friends and relatives: a\u00a0review of the GeoSentinel Surveillance Network. Clin Infect Dis 43(9):1185\u20131193. https:\/\/doi.org\/10.1086\/507893","journal-title":"Clin Infect Dis"},{"key":"3060_CR40","doi-asserted-by":"publisher","DOI":"10.1093\/jtm\/tay123","author":"CT Diagne","year":"2019","unstructured":"Diagne\u00a0CT, Barry\u00a0MA, Ba\u00a0Y, Faye\u00a0O, Sall\u00a0AA (2019) Dengue epidemic in Touba, Senegal: implications for the grand Magal pilgrimage for travelers. J\u00a0Travel Med. https:\/\/doi.org\/10.1093\/jtm\/tay123","journal-title":"J Travel Med"},{"key":"3060_CR41","doi-asserted-by":"publisher","DOI":"10.1093\/jtm\/tav013","author":"D Poddighe","year":"2016","unstructured":"Poddighe\u00a0D, Bonomelli\u00a0I, Giardinetti\u00a0S, Nedbal\u00a0M, Bruni\u00a0P (2016) Paediatric Dengue Fever diagnosed through parents\u2019 epidemiologic report and preventive strategy during the acute phase of infection. J\u00a0Travel Med. https:\/\/doi.org\/10.1093\/jtm\/tav013","journal-title":"J Travel Med"},{"key":"3060_CR42","doi-asserted-by":"publisher","DOI":"10.1093\/jtm\/tax062","author":"S Rabinowicz","year":"2017","unstructured":"Rabinowicz\u00a0S, Schwartz\u00a0E (2017) Morbidity among Israeli paediatric travellers. J\u00a0Travel Med. https:\/\/doi.org\/10.1093\/jtm\/tax062","journal-title":"J Travel Med"},{"issue":"6","key":"3060_CR43","doi-asserted-by":"publisher","first-page":"1525","DOI":"10.4269\/ajtmh.18-0780","volume":"100","author":"Y Tozan","year":"2019","unstructured":"Tozan\u00a0Y, Headley\u00a0TY, Sewe\u00a0MO, Schwartz\u00a0E, Shemesh\u00a0T, Cramer\u00a0JP et al (2019) A prospective study on the impact and out-of-pocket costs of dengue illness in international travelers. Am J Trop Med Hyg 100(6):1525\u20131533. https:\/\/doi.org\/10.4269\/ajtmh.18-0780","journal-title":"Am J Trop Med Hyg"},{"key":"3060_CR44","doi-asserted-by":"publisher","DOI":"10.1093\/jtm\/tay046","author":"R Steffen","year":"2018","unstructured":"Steffen\u00a0R (2018) Travel vaccine preventable diseases-updated logarithmic scale with monthly incidence rates. J\u00a0Travel Med. https:\/\/doi.org\/10.1093\/jtm\/tay046","journal-title":"J Travel Med"},{"key":"3060_CR45","doi-asserted-by":"publisher","DOI":"10.1093\/jtm\/tax046","author":"KM Angelo","year":"2017","unstructured":"Angelo\u00a0KM, Kozarsky\u00a0PE, Ryan\u00a0ET, Chen\u00a0LH, Sotir\u00a0MJ (2017) What proportion of international travellers acquire a\u00a0travel-related illness? A review of the literature. J\u00a0Travel Med. https:\/\/doi.org\/10.1093\/jtm\/tax046","journal-title":"J Travel Med"},{"key":"3060_CR46","doi-asserted-by":"publisher","DOI":"10.1093\/jtm\/tax064","author":"J Torresi","year":"2017","unstructured":"Torresi\u00a0J, Steffen\u00a0R (2017) Redefining priorities towards graded travel-related infectious disease research. J\u00a0Travel Med. https:\/\/doi.org\/10.1093\/jtm\/tax064","journal-title":"J Travel Med"},{"key":"3060_CR47","doi-asserted-by":"publisher","DOI":"10.1093\/jtm\/tay057","author":"A Wilder-Smith","year":"2018","unstructured":"Wilder-Smith\u00a0A (2018) Serostatus-dependent performance of the first licensed dengue vaccine: implications for travellers. J\u00a0Travel Med. https:\/\/doi.org\/10.1093\/jtm\/tay057","journal-title":"J Travel Med"},{"issue":"5","key":"3060_CR48","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1097\/QCO.0000000000000573","volume":"32","author":"A Wilder-Smith","year":"2019","unstructured":"Wilder-Smith\u00a0A (2019) The first licensed dengue vaccine: can it be used in travelers? Curr Opin Infect Dis 32(5):394\u2013400. https:\/\/doi.org\/10.1097\/QCO.0000000000000573","journal-title":"Curr Opin Infect Dis"},{"key":"3060_CR49","doi-asserted-by":"publisher","DOI":"10.1093\/jtm\/tay153","author":"AP Durbin","year":"2019","unstructured":"Durbin\u00a0AP, Gubler\u00a0DJ (2019) What is the prospect of a\u00a0safe and effective dengue vaccine for travelers? J\u00a0Travel Med. https:\/\/doi.org\/10.1093\/jtm\/tay153","journal-title":"J Travel Med"},{"issue":"suppl_1","key":"3060_CR50","doi-asserted-by":"publisher","first-page":"S10","DOI":"10.1093\/jtm\/tay005","volume":"25","author":"L Goodyer","year":"2018","unstructured":"Goodyer\u00a0L, Schofield\u00a0S (2018) Mosquito repellents for the traveller: does picaridin provide longer protection than DEET? J\u00a0Travel Med 25(suppl_1):S10\u2013S15. https:\/\/doi.org\/10.1093\/jtm\/tay005","journal-title":"J Travel Med"}],"container-title":["Bundesgesundheitsblatt - Gesundheitsforschung - Gesundheitsschutz"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00103-019-03060-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00103-019-03060-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00103-019-03060-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,9]],"date-time":"2025-04-09T05:36:41Z","timestamp":1744177001000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00103-019-03060-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,11,29]]},"references-count":50,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,1]]}},"alternative-id":["3060"],"URL":"https:\/\/doi.org\/10.1007\/s00103-019-03060-3","relation":{},"ISSN":["1436-9990","1437-1588"],"issn-type":[{"value":"1436-9990","type":"print"},{"value":"1437-1588","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,11,29]]},"assertion":[{"value":"29 November 2019","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical guidelines"}},{"value":"A.\u00a0Wilder-Smith serves as a consultant to the World Health Organization with regard to dengue vaccines. The views expressed in this article are those of the author and do not necessarily represent the decisions or policies of the World Health Organization.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"For this article no studies with human participants or animals were performed by any of the authors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}